{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T05:15:10Z","timestamp":1722057310078},"reference-count":17,"publisher":"Oceanside Publications Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2023,7,1]]},"DOI":"10.2500\/aap.2023.44.230037","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T04:33:48Z","timestamp":1690000428000},"page":"217-219","source":"Crossref","is-referenced-by-count":1,"title":["A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending"],"prefix":"10.2500","volume":"44","author":[{"given":"Joseph A.","family":"Bellanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell A.","family":"Settipane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2500\/aap.2023.44.230030","article-title":"The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist\/immunologist","volume":"44","author":"Frenkel","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B2","article-title":"FDA approves first respiratory syncytial virus (RSV) vaccine","year":"2023"},{"key":"B3","article-title":"FDA advisory panel votes in favor of Pfizer RSV vaccine","author":"Choi","year":"2023","journal-title":"The Hill"},{"key":"B4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-92-22538","article-title":"Recovery of cytopathogenic agent from chimpanzees with coryza","volume":"92","author":"Blount","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"B5","first-page":"281","article-title":"Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization","volume":"66","author":"Chanock","year":"1957","journal-title":"Am J Hyg"},{"key":"B6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMp2216358","article-title":"The journey to RSV vaccines - heralding an era of structure-based design","volume":"388","author":"Graham","year":"2023","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape","volume":"23","author":"Mazur","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"B8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2500\/aap.2023.44.230016","article-title":"Association of EDN levels in patients with asthma and correlation with FEV1%: a meta-analysis","volume":"44","author":"Kuai","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2500\/aap.2023.44.230014","article-title":"Total serum immunologlobulin E (IgE) as an effective predictor for identifying allergic asthma in childhood asthma","volume":"44","author":"Wang","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2500\/aap.2023.44.230027","article-title":"Clinical value of serum soluble receptor for advanced glycation end products in evaluating the condition of patients with bronchial asthma","volume":"44","author":"Hu","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2500\/aap.2023.44.230022","article-title":"Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: a scoping review","volume":"44","author":"Brake","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2500\/aap.2023.44.230028","article-title":"Peptide immunotherapy for aeroallergens","volume":"44","author":"Midoro-Horiuti","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2500\/aap.2023.44.230015","article-title":"Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis","volume":"44","author":"Peters","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2500\/aap.2023.44.230026","article-title":"Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate","volume":"44","author":"Riedl","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2500\/aap.2023.44.230023","article-title":"Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department","volume":"44","author":"Acquisto","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"B17","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2500\/aap.2023.44.230021","article-title":"Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease","volume":"44","author":"Cihanbeylerden","year":"2023","journal-title":"Allergy Asthma Proc"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2023\/00000044\/00000004\/art00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T04:35:39Z","timestamp":1690346139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2023.44.230037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7,1]]}},"alternative-id":["1088-5412(20230701)44:4L.217;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2023.44.230037","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,1]]}}}